Efficacy of 8 Different Drug Treatments for Patients With Trigeminal Neuralgia: A Network Meta-analysis

Objectives: Trigeminal neuralgia (TN) is commonly seen in older persons and negatively influences their daily life. Although some research on the efficacy of TN drugs has been conducted, the optimal choice still remains uncertain. Therefore, this network meta-analysis (NMA) evaluated the efficacy and performance of 8 drugs with respect to TN. Methods: All literature was retrieved from the PubMed and Embase electronic databases by jointly searching key terms. The only outcome was response rate, expressed as the odds ratio with 95% credible/confidence intervals. Both a pairwise meta-analysis and NMA were conducted. Heat plot and node splitting were computed to measure the consistency between direct and indirect evidence. In addition, surface under cumulative ranking curves were utilized to rank different drugs for treating TN. Results: In total, 13 studies and 672 TN patients were included in this NMA. With regard to the primary endpoint response rate, only lidocaine (LDC), botulinum toxin type A (BTX-A), and carbamazepine (CBZ) had a statistical better performance than the placebo. According to the surface under cumulative ranking curves, LDC, BTX-A, and CBZ are the most effective drugs for treating patients with TN. Conclusions: Among the 8 drugs investigated, all exhibited a capacity to alleviate TN more than the placebo except for pimozide and proparacaine. Moreover, LDC, BTX-A, and CBZ stood out for their high efficacy and could be recommended as the primary choice of treatment for TN.

[1]  Haifeng Zhang,et al.  Two doses of botulinum toxin type A for the treatment of trigeminal neuralgia: observation of therapeutic effect from a randomized, double-blind, placebo-controlled trial , 2014, The Journal of Headache and Pain.

[2]  G. Cruccu,et al.  Natural history and outcome of 200 outpatients with classical trigeminal neuralgia treated with carbamazepine or oxcarbazepine in a tertiary centre for neuropathic pain , 2014, The Journal of Headache and Pain.

[3]  K. Hoshi,et al.  Immediate analgesic effect of 8% lidocaine applied to the oral mucosa in patients with trigeminal neuralgia. , 2014, Pain medicine.

[4]  Muke Zhou,et al.  Non-antiepileptic drugs for trigeminal neuralgia. , 2013, The Cochrane database of systematic reviews.

[5]  G. Zaccara,et al.  Neurological adverse events of new generation sodium blocker antiepileptic drugs. Meta-analysis of randomized, double-blinded studies with eslicarbazepine acetate, lacosamide and oxcarbazepine , 2013, Seizure.

[6]  Hai-Feng Zhang,et al.  Botulinum toxin type A for the treatment of trigeminal neuralgia: results from a randomized, double-blind, placebo-controlled trial , 2012, Cephalalgia : an international journal of headache.

[7]  H. Akram,et al.  Neurosurgical interventions for the treatment of classical trigeminal neuralgia. , 2011, The Cochrane database of systematic reviews.

[8]  S. Shaikh,et al.  Lamotrigine for trigeminal neuralgia: Efficacy and safety in comparison with carbamazepine☆, ☆☆ , 2011, Journal of the Chinese Medical Association : JCMA.

[9]  T. Nurmikko,et al.  EFNS guidelines on the pharmacological treatment of neuropathic pain: 2010 revision , 2010, European journal of neurology.

[10]  R. Gil‐Gouveia,et al.  Neuropsychiatric Side-Effects of Lidocaine: Examples from the Treatment of Headache and a Review , 2009, Cephalalgia : an international journal of headache.

[11]  M. Brainin,et al.  AAN‐EFNS guidelines on trigeminal neuralgia management , 2008, European journal of neurology.

[12]  J. Zakrzewska,et al.  Evidence-based approach to the medical management of trigeminal neuralgia , 2007, British journal of neurosurgery.

[13]  M. Braun,et al.  Botulinum toxin type A injections: adverse events reported to the US Food and Drug Administration in therapeutic and cosmetic cases. , 2005, Journal of the American Academy of Dermatology.

[14]  C. Montecucco,et al.  Botulinal neurotoxins: revival of an old killer. , 2005, Current opinion in pharmacology.

[15]  T. Nurmikko,et al.  Lamotrigine (Lamictal) in refractory trigeminal neuralgia: results from a double-blind placebo controlled crossover trial , 1997, Pain.

[16]  D. Kondziolka,et al.  The effect of single-application topical ophthalmic anesthesia in patients with trigeminal neuralgia. A randomized double-blind placebo-controlled trial. , 1994, Journal of neurosurgery.

[17]  A. Ohsaka,et al.  Local anesthetic lidocaine inhibits the effect of granulocyte colony-stimulating factor on human neutrophil functions. , 1994, Experimental hematology.

[18]  G. Fromm,et al.  A clinical and experimental investigation of the effects of tizanidine in trigeminal neuralgia , 1993, Pain.

[19]  B. van der Dijs,et al.  Pimozide therapy for trigeminal neuralgia. , 1989, Archives of neurology.

[20]  T. Lyberg,et al.  Tizanidine in the Management of Trigeminal Neuralgia , 1986, Cephalalgia : an international journal of headache.

[21]  C. Nicol.  A FOUR YEAR DOUBLE‐BLIND STUDY OF TEGRETOL(r)IN FACIAL PAIN , 1969, Headache.

[22]  K. Sachdev,et al.  A LONG‐TERM LOW‐DOSAGE STUDY OF CARBAMAZEPINE IN TRIGEMINAL NEURALGIA , 1969, Headache.

[23]  A. Marson,et al.  Immediate-release versus controlled-release carbamazepine in the treatment of epilepsy. , 2014, The Cochrane database of systematic reviews.